Cargando…
Mesalamine-induced Myocarditis in a Young Athlete: Can He Run Again?
Mesalamine is often used in the treatment of inflammatory bowel disease (IBD). Mesalamine-induced cardiotoxicity has been reported in the literature and is a rare entity. The mechanism of cardiotoxicity remains unclear, however, it is believed to be due to a humoral-mediated hypersensitivity reactio...
Autores principales: | Ibrahim, Amira, Khalil, Charl, Megaly, Michael, Tawadros, Mariam, Mosleh, Wassim, Corbelli, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440563/ https://www.ncbi.nlm.nih.gov/pubmed/30967978 http://dx.doi.org/10.7759/cureus.3978 |
Ejemplares similares
-
A Partial Anomalous Pulmonary Venous Connection in a Severely Symptomatic Patient, Is Surgery Always Recommended?
por: Khalil, Charl, et al.
Publicado: (2018) -
Mesalamine-Induced Myocarditis
por: Merceron, Olivier, et al.
Publicado: (2010) -
Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine
por: Karki, Pratul, et al.
Publicado: (2023) -
Focal Myocarditis As the First Sign in the Presentation of a COVID-19 Infection: A Case Report
por: Zayour, Mohamad, et al.
Publicado: (2022) -
Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
por: Okoro, Kelechukwu U., et al.
Publicado: (2018)